QUADRASA 2 g, powder for rectal solution 7 bottles of 4.2 g
Active ingredients: Aminosalicylate sodium dihydrate, P A S SODIQUE ANHYDRE
Commercialized according to BDPM
Powder for solution7 bottles of 4.2 grectale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- QUADRASA 2 g, poudre pour solution rectale
- Pharmaceutical form
- poudre pour solution
- Route of administration
- rectale
- Presentation description
- 7 flacon(s) polyéthylène de 4,2 g avec canule
- Marketing authorisation holder
- NORGINE (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 8 Feb 2024
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60382608CIP73425409CIP133400934254093Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| AMINOSALICYLATE DE SODIUM DIHYDRATÉpoudre | 2 g · un flacon | SA |
| P A S SODIQUE ANHYDREpoudre | 1,659 g · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.